» Articles » PMID: 23805139

Lessons to Be Learned from Natural Control of HIV - Future Directions, Therapeutic, and Preventive Implications

Overview
Journal Front Immunol
Date 2013 Jun 28
PMID 23805139
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating data generated from persons who naturally control HIV without the need for antiretroviral treatment has led to significant insights into the possible mechanisms of durable control of AIDS virus infection. At the center of this control is the HIV-specific CD8 T cell response, and the basis for this CD8-mediated control is gradually being revealed. Genome wide association studies coupled with HLA sequence data implicate the nature of the HLA-viral peptide interaction as the major genetic factor modulating durable control of HIV, but host genetic factors account for only around 20% of the variability in control. Other factors including specific functional characteristics of the TCR clonotypes generated in vivo, targeting of vulnerable regions of the virus that lead to fitness impairing mutations, immune exhaustion, and host restriction factors that limit HIV replication all have been shown to additionally contribute to control. Moreover, emerging data indicate that the CD8(+) T cell response may be critical for attempts to purge virus infected cells following activation of the latent reservoir, and thus lessons learned from elite controllers (ECs) are likely to impact the eradication agenda. On-going efforts are also needed to understand and address the role of immune activation in disease progression, as it becomes increasingly clear that durable immune control in ECs comes at a cost. Taken together, the research achievements in the attempt to unlock the mechanisms behind natural control of HIV will continue to be an important source of insights and ideas in the continuous search after an effective HIV vaccine, and for the attempts to achieve a sterilizing or functional cure in HIV positive patients with progressive infection.

Citing Articles

Bispecific T cell engagers and their synergistic tumor immunotherapy with oncolytic viruses.

Huang Q, Cai W, Han Z, Wang M, Zhou Y, Cheng J Am J Cancer Res. 2021; 11(6):2430-2455.

PMID: 34249409 PMC: 8263669.


Persistent HIV-controllers are more prone to spontaneously clear HCV: a retrospective cohort study.

Dominguez-Molina B, Tarancon-Diez L, Milanes-Guisado Y, Genebat M, Resino S, Rodriguez C J Int AIDS Soc. 2020; 23(9):e25607.

PMID: 32909370 PMC: 7507465. DOI: 10.1002/jia2.25607.


Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection.

Tarancon-Diez L, Rodriguez-Gallego E, Rull A, Peraire J, Vilades C, Portilla I EBioMedicine. 2019; 42:86-96.

PMID: 30879922 PMC: 6491381. DOI: 10.1016/j.ebiom.2019.03.004.


Targeting the Latent Reservoir for HIV-1.

Sengupta S, Siliciano R Immunity. 2018; 48(5):872-895.

PMID: 29768175 PMC: 6196732. DOI: 10.1016/j.immuni.2018.04.030.


Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs.

Brozy J, Schlaepfer E, Mueller C, Rochat M, Rampini S, Myburgh R J Virol. 2018; 92(14).

PMID: 29720517 PMC: 6026749. DOI: 10.1128/JVI.00491-18.


References
1.
Morse C, Dodd L, Nghiem K, Costello R, Csako G, Lane H . Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults. AIDS. 2012; 27(4):591-5. PMC: 5507350. DOI: 10.1097/QAD.0b013e32835c206a. View

2.
Lambotte O, Ferrari G, Moog C, Yates N, Liao H, Parks R . Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS. 2009; 23(8):897-906. PMC: 3652655. DOI: 10.1097/QAD.0b013e328329f97d. View

3.
Huang J, Burke P, Cung T, Pereyra F, Toth I, Walker B . Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. J Virol. 2010; 84(18):9463-71. PMC: 2937602. DOI: 10.1128/JVI.01009-10. View

4.
Deeks S, Walker B . Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity. 2007; 27(3):406-16. DOI: 10.1016/j.immuni.2007.08.010. View

5.
Fellay J, Shianna K, Ge D, Colombo S, Ledergerber B, Weale M . A whole-genome association study of major determinants for host control of HIV-1. Science. 2007; 317(5840):944-7. PMC: 1991296. DOI: 10.1126/science.1143767. View